Product References
Myometrial-derived CXCL12 promotes lipopolysaccharide induced preterm labour by regulating macrophage migration, polarization and function in mice.
Journal of cellular and molecular medicine
Zhang L,Mamillapalli R,Habata S,McAdow M,Taylor HS
PA3-305 was used in Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot to show that smooth muscle cell treatment for pre-term labour (PTL) in mice with AMD3100 reduces lipopolysaccharide-induced PTL through blocking of CXCL12/CXCR4 signalling.
Sun May 01 00:00:00 EDT 2022
Lidocaine inhibited migration of NSCLCA549 cells via the CXCR4 regulation.
Cancer biomarkers : section A of Disease markers
Xing B,Yang L,Cui Y
PA3-305 was used in Western Blotting to show that Lidocaine at clinical plasma concentrations inhibited CXCL12-induced CXCR4 activation, thereby reduced the intracellular Ca2+-dependent cytoskeleton remodeling, resulting in slower migration of A549 cells.
Tue Apr 19 00:00:00 EDT 2022
Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10.
Stem cell research & therapy
Hervás-Salcedo R,Fernández-García M,Hernando-Rodríguez M,Quintana-Bustamante O,Segovia JC,Alvarez-Silva M,García-Arranz M,Minguez P,Del Pozo V,de Alba MR,García-Olmo D,Ayuso C,Lamana ML,Bueren JA,Yañez RM
PA3-305 was used in Immunocytochemistry to show that the transient co-expression of CXCR4 and IL10 enhances the therapeutic potential of mesenchymal stromal cells in a local inflammation mouse model.
Fri Feb 12 00:00:00 EST 2021
Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10.
Stem cell research & therapy
Hervás-Salcedo R,Fernández-García M,Hernando-Rodríguez M,Quintana-Bustamante O,Segovia JC,Alvarez-Silva M,García-Arranz M,Minguez P,Del Pozo V,de Alba MR,García-Olmo D,Ayuso C,Lamana ML,Bueren JA,Yañez RM
PA3-305 was used in Immunocytochemistry to show that the transient co-expression of CXCR4 and IL10 enhances the therapeutic potential of mesenchymal stromal cells in a local inflammation mouse model.
Fri Feb 12 00:00:00 EST 2021
CXCL12 enhances pregnancy outcome via improvement of endometrial receptivity in mice.
Scientific reports
Koo HS,Yoon MJ,Hong SH,Ahn J,Cha H,Lee D,Ko JE,Kwon H,Choi DH,Lee KA,Ko JJ,Kang YJ
PA3-305 was used in Immunohistochemistry to develop a minimally-invasive therapeutic strategy for clinical treatment or supplement for the patients with repeated implantation failure with less risk.
Thu Apr 01 00:00:00 EDT 2021
CXCL12 enhances pregnancy outcome via improvement of endometrial receptivity in mice.
Scientific reports
Koo HS,Yoon MJ,Hong SH,Ahn J,Cha H,Lee D,Ko JE,Kwon H,Choi DH,Lee KA,Ko JJ,Kang YJ
PA3-305 was used in Immunohistochemistry to develop a minimally-invasive therapeutic strategy for clinical treatment or supplement for the patients with repeated implantation failure with less risk.
Thu Apr 01 00:00:00 EDT 2021
Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias.
Biology
Janjetovic S,Lohneis P,Nogai A,Balci D,Rasche L,Jähne D,Bokemeyer C,Schilling G,Blau IW,Schmidt-Hieber M
PA3-305 was used in Immunohistochemistry to obtain insights into the molecular mechanisms of extramedullary spread of clonal plasma cells.
Tue Jul 06 00:00:00 EDT 2021
Loss of Cxcr4 in Endometriosis Reduces Proliferation and Lesion Number while Increasing Intraepithelial Lymphocyte Infiltration.
The American journal of pathology
Tal A,Tal R,Kliman HJ,Taylor HS
PA3-305 was used in Immunohistochemistry-immunofluorescence to explore the effects of targeted disruption of CXCR4 in endometriosis lesions.
Thu Jul 01 00:00:00 EDT 2021
CXCL12-CXCR4 Interplay Facilitates Palatal Osteogenesis in Mice.
Frontiers in cell and developmental biology
Verheijen N,Suttorp CM,van Rheden REM,Regan RF,Helmich MPAC,Kuijpers-Jagtman AM,Wagener FADTG
Published figure using CXCR4 polyclonal antibody (Product # PA3-305) in Immunohistochemistry
Mon Sep 28 00:00:00 EDT 2020
CXCL12-CXCR4 Interplay Facilitates Palatal Osteogenesis in Mice.
Frontiers in cell and developmental biology
Verheijen N,Suttorp CM,van Rheden REM,Regan RF,Helmich MPAC,Kuijpers-Jagtman AM,Wagener FADTG
Published figure using CXCR4 polyclonal antibody (Product # PA3-305) in Immunohistochemistry
Mon Sep 28 00:00:00 EDT 2020
An injectable hydrogel-formulated inhibitor of prolyl-4-hydroxylase promotes T regulatory cell recruitment and enhances alveolar bone regeneration during resolution of experimental periodontitis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Nagai K,Ideguchi H,Kajikawa T,Li X,Chavakis T,Cheng J,Messersmith PB,Heber-Katz E,Hajishengallis G
PA3-305 was used in Immunohistochemistry to show that the administration of 1,4-DPCA/hydrogel at the onset of periodontitis resolution promotes CXCR4-dependent accumulation of Treg cells and alveolar bone regeneration, suggesting a novel approach for regaining bone lost due to periodontitis.
Thu Oct 01 00:00:00 EDT 2020
CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking.
Journal of cellular and molecular medicine
Pluchino N,Mamillapalli R,Shaikh S,Habata S,Tal A,Gaye M,Taylor HS
PA3-305 was used in Immunohistochemistry (Paraffin) to propose that CXCR4 and CXCR7 antagonists can be used as potential novel, non-hormonal therapies for endometriosis.
Sat Feb 01 00:00:00 EST 2020
CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking.
Journal of cellular and molecular medicine
Pluchino N,Mamillapalli R,Shaikh S,Habata S,Tal A,Gaye M,Taylor HS
PA3-305 was used in Immunohistochemistry (Paraffin) to propose that CXCR4 and CXCR7 antagonists can be used as potential novel, non-hormonal therapies for endometriosis.
Sat Feb 01 00:00:00 EST 2020
CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking.
Journal of cellular and molecular medicine
Pluchino N,Mamillapalli R,Shaikh S,Habata S,Tal A,Gaye M,Taylor HS
PA3-305 was used in Immunohistochemistry (Paraffin) to propose that CXCR4 and CXCR7 antagonists can be used as potential novel, non-hormonal therapies for endometriosis.
Sat Feb 01 00:00:00 EST 2020
Oral lichen planus interactome reveals CXCR4 and CXCL12 as candidate therapeutic targets.
Scientific reports
Rivera C,Crisóstomo MF,Peña C,González-Díaz P,González-Arriagada WA
PA3-305 was used in Immunohistochemistry to support the pathological role of chemokines and chemokine receptors in oral lichen planus.
Wed Mar 25 00:00:00 EDT 2020
Oral lichen planus interactome reveals CXCR4 and CXCL12 as candidate therapeutic targets.
Scientific reports
Rivera C,Crisóstomo MF,Peña C,González-Díaz P,González-Arriagada WA
PA3-305 was used in Immunohistochemistry to support the pathological role of chemokines and chemokine receptors in oral lichen planus.
Wed Mar 25 00:00:00 EDT 2020
Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth.
Medicina oral, patologia oral y cirugia bucal
Domingueti CB,Janini JB,Paranaíba LM,Lozano-Burgos C,Olivero P,González-Arriagada WA
PA3-305 was used in Immunohistochemistry to evaluate the prognostic value of the immunoexpression of chemokines in squamous cell carcinoma of tongue and floor of the mouth.
Wed May 01 00:00:00 EDT 2019
Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth.
Medicina oral, patologia oral y cirugia bucal
Domingueti CB,Janini JB,Paranaíba LM,Lozano-Burgos C,Olivero P,González-Arriagada WA
PA3-305 was used in Immunohistochemistry to evaluate the prognostic value of the immunoexpression of chemokines in squamous cell carcinoma of tongue and floor of the mouth.
Wed May 01 00:00:00 EDT 2019
Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis.
Arthritis & rheumatology (Hoboken, N.J.)
Nicastro M,Vescovini R,Maritati F,Palmisano A,Urban ML,Incerti M,Fenaroli P,Peyronel F,Benigno GD,Mangieri D,Volpi R,Becchi G,Romagnani P,Corradi D,Vaglio A
PA3-305 was used in Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot to indicate that fibrocytes are enriched in the peripheral blood of CP patients and infiltrate target lesions and that the accumulation of fibrocytes in the pathologic tissue might be driven by CXCL12, and Th2-skewed immune responses are likely to facilitate their differentiation.
Fri Nov 01 00:00:00 EDT 2019
CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
Oncology reports
Benedicto A,Romayor I,Arteta B
PA3-305 was used in Western Blotting to investigate the effectiveness of CXCR4 receptor blockage, and its mechanisms, in reducing metastatic growth in the liver.
Sun Apr 01 00:00:00 EDT 2018
Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma.
Theranostics
Séhédic D,Chourpa I,Tétaud C,Griveau A,Loussouarn C,Avril S,Legendre C,Lepareur N,Wion D,Hindré F,Davodeau F,Garcion E
PA3-305 was used in Immunohistochemistry to investigate the efficacy of a novel system of local brain internal radiation therapy, combining a radiopharmaceutical with an immuno-nanoparticle.
Mon Mar 19 00:00:00 EDT 2018
CXCR4 regulates interneuron migration in the developing neocortex.
The Journal of neuroscience : the official journal of the Society for Neuroscience
Stumm RK,Zhou C,Ara T,Lazarini F,Dubois-Dalcq M,Nagasawa T,Höllt V,Schulz S
PA3-305 was used in immunohistochemistry to investigate the important role of CXCR4 in interneuron migration
Sun Jun 15 00:00:00 EDT 2003